ADENTRA (TSE:ADEN - Get Free Report) had its price objective increased by investment analysts at Scotiabank from C$39.00 to C$40.00 in a report issued on Friday,BayStreet.CA reports.
A number of other research analysts also recently issued reports on the stock. Desjardins upped their target price on shares of ADENTRA from C$41.00 to C$47.00 and gave the company a "buy" rating in a research report on Monday, September 29th. Stifel Nicolaus lowered their target price on shares of ADENTRA from C$51.00 to C$45.00 and set a "buy" rating for the company in a report on Tuesday, October 7th. Finally, National Bankshares lifted their target price on shares of ADENTRA from C$41.00 to C$42.50 and gave the stock an "outperform" rating in a report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy".
View Our Latest Stock Analysis on ADENTRA
ADENTRA Stock Performance
Shares of TSE:ADEN traded up $0.76 during midday trading on Friday, hitting $34.30. The company's stock had a trading volume of 22,303 shares, compared to its average volume of 63,980. The stock's 50 day simple moving average is $34.55 and its 200 day simple moving average is $30.09. The stock has a market capitalization of $837.23 million, a price-to-earnings ratio of 19.49 and a beta of 1.25. ADENTRA has a fifty-two week low of $24.60 and a fifty-two week high of $42.67.
ADENTRA Company Profile
(
Get Free Report)
Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ADENTRA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ADENTRA wasn't on the list.
While ADENTRA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.